Responses at EOI (N = 40)
| Response . | Modified Lugano 2014 (PET-CT) . | Lugano 2014 (PET) . | Cheson 2007 (PET-CT) . | |||
|---|---|---|---|---|---|---|
| IRC . | INV . | IRC . | INV . | IRC . | INV . | |
| ORR, n (%) | 34 (85.0) | 38 (95.0) | 36 (90.0) | 38 (95.0) | 36 (90.0) | 38 (95.0) |
| CR, n (%) | 30 (75.0) | 34 (85.0) | 30 (75.0) | 35 (87.5) | 30 (75.0) | 32 (80.0) |
| PR, n (%) | 4 (10.0) | 4 (10.0) | 6 (15.0) | 3 (7.5) | 6 (15.0) | 6 (15.0) |
| SD, n (%) | 4 (10.0) | 0 | 2 (5.0) | 0 | 2 (5.0) | 0 |
| NA, n (%)∗ | 2 (5.0) | 2 (5.0) | 2 (5.0) | 2 (5.0) | 2 (5.0) | 2 (5.0) |
| Response . | Modified Lugano 2014 (PET-CT) . | Lugano 2014 (PET) . | Cheson 2007 (PET-CT) . | |||
|---|---|---|---|---|---|---|
| IRC . | INV . | IRC . | INV . | IRC . | INV . | |
| ORR, n (%) | 34 (85.0) | 38 (95.0) | 36 (90.0) | 38 (95.0) | 36 (90.0) | 38 (95.0) |
| CR, n (%) | 30 (75.0) | 34 (85.0) | 30 (75.0) | 35 (87.5) | 30 (75.0) | 32 (80.0) |
| PR, n (%) | 4 (10.0) | 4 (10.0) | 6 (15.0) | 3 (7.5) | 6 (15.0) | 6 (15.0) |
| SD, n (%) | 4 (10.0) | 0 | 2 (5.0) | 0 | 2 (5.0) | 0 |
| NA, n (%)∗ | 2 (5.0) | 2 (5.0) | 2 (5.0) | 2 (5.0) | 2 (5.0) | 2 (5.0) |
INV, investigator; NA, not available.
Patients were not evaluable because of death due to an AE prior to response assessment.